New Delhi, Sept. 18 -- The Union health ministry on Thursday said it has issued an advisory for states to ensure that stem cell therapy is offered as standard clinical care only for approved disease conditions. Also, its use for autism still remains restricted to clinical trials approved by the authorities concerned. ".the advisory has been issued in view of the judgment dated 30 January 2026 of the Hon'ble Supreme Court in Yash Charitable Trust & Ors. v. Union of India & Ors., W.P. (C) No. 369 of 2022. The advisory reiterates the existing framework governing stem cell research and therapy and seeks to ensure that stem cell therapy is permitted as standard care in routine clinical practice only for disease conditions/indications included in...